CTC
IBB icon

Central Trust Company’s iShares Biotechnology ETF IBB Stock Holding History

Central Trust Company’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.26M Sell
13,389
-353
-3% -$60.4K 0.04% 232
2025
Q4 		$2.32M Hold
13,742
– – 0.05% 230
2025
Q3 		$1.98M Sell
13,742
-13
-0.1% -$1.77K 0.04% 259
2025
Q2 		$1.74M Sell
13,755
-104
-0.8% -$12.8K 0.04% 262
2025
Q1 		$1.77M Sell
13,859
-431
-3% -$58.4K 0.04% 248
2024
Q4 		$1.89M Sell
14,290
-200
-1% -$28.1K 0.05% 244
2024
Q3 		$2.11M Sell
14,490
-80
-0.5% -$11.6K 0.05% 228
2024
Q2 		$2M Hold
14,570
– – 0.05% 228
2024
Q1 		$2M Sell
14,570
-100
-0.7% -$13.7K 0.05% 230
2023
Q4 		$1.99M Sell
14,670
-168
-1% -$20.5K 0.05% 220
2023
Q3 		$1.81M Buy
14,838
+174
+1% +$22.1K 0.05% 225
2023
Q2 		$1.86M Sell
14,664
-593
-4% -$77K 0.05% 224
2023
Q1 		$1.97M Sell
15,257
-949
-6% -$124K 0.06% 217
2022
Q4 		$2.13M Sell
16,206
-1,475
-8% -$191K 0.07% 211
2022
Q3 		$2.07M Sell
17,681
-459
-3% -$57K 0.07% 201
2022
Q2 		$2.13M Sell
18,140
-432
-2% -$51.3K 0.07% 205
2022
Q1 		$2.42M Sell
18,572
-309
-2% -$40.3K 0.07% 214
2021
Q4 		$2.88M Buy
18,881
+22
+0.1% +$3.41K 0.08% 195
2021
Q3 		$3.05M Sell
18,859
-50
-0.3% -$8.41K 0.11% 162
2021
Q2 		$3.1M Sell
18,909
-453
-2% -$69.8K 0.11% 160
2021
Q1 		$2.92M Buy
19,362
+456
+2% +$72.4K 0.11% 153
2020
Q4 		$2.86M Sell
18,906
-2,106
-10% -$301K 0.12% 146
2020
Q3 		$2.85M Buy
21,012
+1,210
+6% +$164K 0.13% 130
2020
Q2 		$2.71M Sell
19,802
-129
-0.6% -$16.4K 0.14% 134
2020
Q1 		$2.15M Buy
19,931
+476
+2% +$54.8K 0.13% 138
2019
Q4 		$2.34M Buy
19,455
+1,546
+9% +$172K 0.12% 146
2019
Q3 		$1.78M Sell
17,909
-470
-3% -$49.2K 0.1% 171
2019
Q2 		$1.97M Sell
18,379
-45
-0.2% -$4.79K 0.11% 162
2019
Q1 		$2.06M Buy
18,424
+32
+0.2% +$3.51K 0.12% 150
2018
Q4 		$1.77M Buy
18,392
+237
+1% +$25.2K 0.12% 160
2018
Q3 		$2.21M Sell
18,155
-815
-4% -$96K 0.13% 157
2018
Q2 		$2.08M Sell
18,970
-1,187
-6% -$127K 0.13% 153
2018
Q1 		$2.15M Sell
20,157
-1,295
-6% -$144K 0.14% 153
2017
Q4 		$2.29M Sell
21,452
-55
-0.3% -$5.88K 0.14% 144
2017
Q3 		$2.39M Sell
21,507
-270
-1% -$28.9K 0.15% 134
2017
Q2 		$2.25M Sell
21,777
-5,205
-19% -$513K 0.15% 144
2017
Q1 		$2.64M Buy
26,982
+384
+1% +$36.8K 0.18% 133
2016
Q4 		$2.35M Sell
26,598
-4,395
-14% -$400K 0.16% 143
2016
Q3 		$2.99M Buy
30,993
+10,524
+51% +$1M 0.22% 117
2016
Q2 		$1.76M Buy
20,469
+816
+4% +$73.2K 0.13% 157
2016
Q1 		$1.71M Buy
19,653
+2,058
+12% +$184K 0.13% 157
2015
Q4 		$1.99M Buy
17,595
+489
+3% +$53.1K 0.16% 133
2015
Q3 		$1.73M Buy
17,106
+231
+1% +$27.7K 0.15% 142
2015
Q2 		$2.08M Buy
16,875
+11,940
+242% +$1.43M 0.16% 137
2015
Q1 		$565K Buy
4,935
+159
+3% +$17.5K 0.05% 278
2014
Q4 		$483K Buy
4,776
+282
+6% +$27.4K 0.04% 298
2014
Q3 		$410K Sell
4,494
-150
-3% -$13.2K 0.03% 331
2014
Q2 		$398K Buy
4,644
+1,275
+38% +$100K 0.03% 341
2014
Q1 		$266K Buy
3,369
+882
+35% +$73.5K 0.02% 385
2013
Q4 		$188K Buy
2,487
+150
+6% +$10.6K 0.02% 426
2013
Q3 		$163K Buy
2,337
+2,250
+2,586% +$147K 0.01% 431
2013
Q2 		$5K Buy
+87
New +$5.03K ﹤0.01% 1005

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Central Trust Company's IBB Position: Q1 2026 in Review

Central Trust Company reduced its iShares Biotechnology ETF (IBB) stake by 2.6% in Q1 2026, selling an estimated $60.4K and leaving 13,389 shares worth $2.26M. The position accounts for 0.04% of the portfolio, ranked #232.

Central Trust Company first reported a position in IBB in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.1M in Q2 2021. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Central Trust Company held 13,389 shares of iShares Biotechnology ETF worth $2.26M as of Q1 2026.
  • Central Trust Company sold 353 iShares Biotechnology ETF shares in Q1 2026, an estimated $60.4K.
  • iShares Biotechnology ETF made up 0.04% of Central Trust Company's portfolio in Q1 2026, its #232 holding.
  • Central Trust Company first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 52 quarters since.
  • Central Trust Company's iShares Biotechnology ETF position peaked at $3.1M in Q2 2021.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Central Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.